| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/19/1992 | WO1992016555A1 Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers |
| 09/19/1992 | CA2736076A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 09/19/1992 | CA2101918A1 Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers |
| 09/18/1992 | CA2063239A1 Stimulating factor of the neu receptor |
| 09/17/1992 | WO1992015699A1 High affinity humanized monoclonal antibodies |
| 09/17/1992 | WO1992015696A1 Method for production of a vegetable protein hydrolyzate and a use thereof |
| 09/17/1992 | WO1992015694A1 Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor |
| 09/17/1992 | WO1992015693A1 Chimeric tar enzyme construction for hiv therapy |
| 09/17/1992 | WO1992015691A1 Biocidal proteins |
| 09/17/1992 | WO1992015686A1 Modified factor vii |
| 09/17/1992 | WO1992015680A1 Methods and compositions for the selective inhibition of gene expression |
| 09/17/1992 | WO1992015677A1 Process for the development of binding mini-proteins |
| 09/17/1992 | WO1992015671A1 Soluble cd28 proteins and methods of treatment therewith |
| 09/17/1992 | WO1992015615A1 Serum calcium depressing factor |
| 09/17/1992 | WO1992015614A1 Method for the stabilization of methionine-containing polypeptides |
| 09/17/1992 | WO1992015613A1 Improved preparation of cat dander allergens for immunotherapeutic purposes and uses therefor |
| 09/17/1992 | WO1992015612A1 Curculin b, dna coding for the same, and production of both of them |
| 09/17/1992 | WO1992015611A1 Novel insulin derivatives |
| 09/17/1992 | WO1992015609A1 Compositions and methods to inhibit the activation of active factor xiii |
| 09/17/1992 | WO1992015607A2 Phenyl amidines derivatives useful as platelet aggregation inhibitors |
| 09/17/1992 | WO1992015606A1 New inhibitors of endothelial cell proliferation |
| 09/17/1992 | WO1992015605A2 Inhibitors of human neutrophil elastase and human cathepsin g |
| 09/17/1992 | WO1992015603A1 Prad1 cyclin and its cdna |
| 09/17/1992 | WO1992015602A1 Cancer diagnosis and therapy |
| 09/17/1992 | WO1992015600A1 Cancer diagnosis and therapy |
| 09/17/1992 | WO1992015558A1 Indian derivative and thromboxane antagonist containing the same |
| 09/17/1992 | WO1992015330A1 Method for anti-lhrh immunoneutralization for ungelded male domestic animals and peptide therefor |
| 09/17/1992 | WO1992015329A1 Methods and pharmaceutical compositions for inhibiting protease from human immunodeficiency virus |
| 09/17/1992 | WO1992015327A1 Recombinant double chain immunotoxins |
| 09/17/1992 | WO1992015324A1 Preparation of factor ix |
| 09/17/1992 | WO1992015323A1 Protein-induced morphogenesis |
| 09/17/1992 | WO1992015322A1 Redirection of cellular immunity by receptor chimeras |
| 09/17/1992 | WO1992015320A1 Antigen recognized by patients with antibody associated paraneoplastic sensory neuronopathy, dna encoding same and uses thereof |
| 09/17/1992 | WO1992015319A1 Hiv protease inhibitors |
| 09/17/1992 | WO1992015318A1 Use of cell surface receptor targeted molecules for the treatment of viral diseases |
| 09/17/1992 | WO1992015317A1 Synthetic preparation of amylin and amylin analogues |
| 09/17/1992 | WO1992015316A1 Modified proteins and their use for controlling viral infections |
| 09/17/1992 | WO1992015279A1 Cosmetic composition containing at least one purified peptide as active principle obtainable by hydrolysis of casein with opiod activity |
| 09/17/1992 | WO1992013553A3 Method and agents for promoting wound healing |
| 09/17/1992 | WO1992013072A3 Process for the synthesis and purification of human ciliary neuronotrophic factor (cntf) from escherichia coli |
| 09/17/1992 | WO1992012960A3 Derivatives of dicarboxylic acids having six to twelve carbon atoms and use of these derivatives and dicarboxylic acids alone in the preparation of pharmaceutical compositions for enteral and parenteral nutrition |
| 09/17/1992 | WO1992011025A3 Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases |
| 09/17/1992 | CA2108144A1 Methods and compositions for the selective inhibition of gene expression |
| 09/17/1992 | CA2106092A1 Biocidal proteins |
| 09/17/1992 | CA2105863A1 Compositions and methods to inhibit the activation of active factor xiii |
| 09/17/1992 | CA2104964A1 Cancer diagnosis and therapy with tumor suppressor genes |
| 09/17/1992 | CA2104958A1 Use of cell surface receptor targeted molecules for the treatment of viral diseases |
| 09/16/1992 | WO1992016845A1 Receptor-based screening methods for amylin agonists and antagonists |
| 09/16/1992 | WO1992016623A2 Receptors for bombesin-like peptides |
| 09/16/1992 | WO1992016222A1 Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions |
| 09/16/1992 | WO1992016221A1 Pegylation of polypeptides |
| 09/16/1992 | WO1992016192A1 Pulmonary administration of granulocyte colony stimulating factor |
| 09/16/1992 | EP0504064A1 Novel thrombin inhibitors |
| 09/16/1992 | EP0504055A1 Compositions comprising glucides for use in diet and therapy, and their uses |
| 09/16/1992 | EP0503991A1 Process for preparing a highly purified standardized concentrate of human von Willebrand factor on industrial scale, appropriate for therapeutic use |
| 09/16/1992 | EP0503960A1 Cyclic lipopeptides having antibiotic activity |
| 09/16/1992 | EP0503939A1 Antimicrobial peptide and antimicrobial agent |
| 09/16/1992 | EP0503829A2 Hirudin for the inhibition of cancer metastasis |
| 09/16/1992 | EP0503827A1 Amylin and calcitonin gene-related peptide use and antagonists thereof |
| 09/16/1992 | EP0503710A2 Flunarizine containing anti-neoplastic compositions |
| 09/16/1992 | EP0503648A1 CD2-Binding domain of lymphocyte function associated antigen 3 |
| 09/16/1992 | EP0503646A1 Monoclonal antibodies recognizing lymphocyte function associated antigen-3 |
| 09/16/1992 | EP0503583A1 Composition for sustained release of erythropoietin |
| 09/16/1992 | EP0503538A1 Medicinal composition containing an anthelmintic cyclic depsipeptide |
| 09/16/1992 | EP0503505A1 Purified mite allergen |
| 09/16/1992 | EP0503484A2 Monoclonal antibodies as antidotes |
| 09/16/1992 | EP0503301A2 Peptide derivatives and application thereof |
| 09/16/1992 | EP0503297A1 GLIA activating factor and its production |
| 09/16/1992 | EP0503203A1 Novel thrombin inhibitors |
| 09/16/1992 | EP0503055A1 Inhibitor of lymphocyte response and immune-related disease |
| 09/16/1992 | EP0503050A1 Hybrid growth factors |
| 09/16/1992 | EP0503044A1 Peptide compounds of laevorotatory amino acids and ring molecules, and therapeutical applications thereof. |
| 09/16/1992 | EP0503002A1 Antisense oligonucleotide inhibition of papillomavirus |
| 09/16/1992 | EP0502997A1 Treatment of atopic disorders with gamma-interferon. |
| 09/16/1992 | EP0502987A1 Acylated bradykinin antagonists and uses therefor. |
| 09/16/1992 | EP0502962A1 Hirudine polyalkylene glycol conjugates. |
| 09/16/1992 | EP0502949A1 Homologous guluronic acid alginate coating composition for in-vivo application and implantation and method of using same |
| 09/16/1992 | EP0502927A1 Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor |
| 09/16/1992 | EP0502897A1 Endothelial-derived il-8 |
| 09/16/1992 | EP0502892A1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
| 09/16/1992 | EP0502878A1 Protection of intraocular structures |
| 09/16/1992 | EP0502874A1 Novel peptides derived from neuropeptide y |
| 09/16/1992 | EP0470128A4 Active carbonates of polyalkylene oxides for modification of polypeptides |
| 09/16/1992 | CA2105306A1 Receptors for bombesin-like peptides |
| 09/16/1992 | CA2082929A1 Receptor-based screening methods for amylin agonists and antagonists |
| 09/16/1992 | CA2063039A1 Use of phosphatidylserine and its derivatives in degenerative pathologies also associated with immune disfunctions |
| 09/16/1992 | CA2063018A1 Lipopeptide derivatives |
| 09/16/1992 | CA2063005A1 Amylin and calcitonin gene-related peptide use and antagonists thereof |
| 09/15/1992 | WO1992016559A1 The trk tyrosine kinase receptor is the physiological receptor for nerve growth factor |
| 09/15/1992 | WO1992016228A1 TGF-β1/β2: A NOVEL CHIMERIC TRANSFORMING GROWTH FACTOR-BETA |
| 09/15/1992 | WO1991013989A1 Methods and compositions for the treatment of malignancies in which a protein kinase is associated |
| 09/15/1992 | US5147865 Phosphonopyrrolidine- and piperidine-containing pseudopeptides of the statin type, a process for their preparation and their use as medicaments against retroviruses |
| 09/15/1992 | US5147856 Administering cyclic peptide prior to, during, and after surgery |
| 09/15/1992 | US5147855 Modified vasoactive intestinal peptide |
| 09/15/1992 | US5147854 Tgf-b compositions and method |
| 09/15/1992 | US5147853 Infection protectant |
| 09/15/1992 | US5147803 Using (di- or tri)peptides |
| 09/15/1992 | US5147799 Repopulation of macrophages and granulocytes using transforming growth factor-beta |
| 09/15/1992 | US5147790 Tissue plasminogen activator, biosynthesis |
| 09/15/1992 | US5147789 For production of polypeptide analog of an animal growth hormone |